Cargando…
Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan
In Japan, the serious adverse events after human papillomavirus (HPV) vaccination were widely reported in the media. The Ministry of Health, Labour and Welfare of Japan (MHLW) announced the suspension of the governmental recommendation of HPV vaccine in 2013, and the inoculation rate has since sharp...
Autores principales: | Nakagawa, Satoshi, Ueda, Yutaka, Yagi, Asami, Ikeda, Sayaka, Hiramatsu, Kosuke, Kimura, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293087/ https://www.ncbi.nlm.nih.gov/pubmed/32248632 http://dx.doi.org/10.1111/cas.14406 |
Ejemplares similares
-
The ‘best friend effect’: a promising tool to encourage HPV vaccination in Japan
por: Yagi, Asami, et al.
Publicado: (2022) -
Improved long‐term survival of corpus cancer in Japan: A 40‐year population‐based analysis
por: Yagi, Asami, et al.
Publicado: (2021) -
Intentions for catch-up HPV vaccination in Japan: an internet survey
por: Nakagawa, Satoshi, et al.
Publicado: (2023) -
A nationwide birth year‐by‐year analysis of effectiveness of HPV vaccine in Japan
por: Yagi, Asami, et al.
Publicado: (2021) -
Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine
por: Yagi, Asami, et al.
Publicado: (2020)